Grant
Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commer
Opens soon
This is a forecasted US Small Business Innovation Research (SBIR) Phase IIB grant opportunity to accelerate cancer-relevant technologies toward commercialization.
Key facts
- Deadline
- No fixed deadline
- Amount
- Grant
- Equity
- None
- Entry fee
- Free to apply
- Open to
- United States
- Sectors
- Biotech, Healthtech
- Application languages
- English
Verified on September 28, 2026 against the official page.
Facts are summarised from the official page and can change without notice. Always confirm the rules and deadline there before you apply.